You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

lymphocytic density

Showing 1 - 25 of 4,224
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Trial in Scottsdale, Rochester (Biospecimen Collection, Cardiopulmonary

Recruiting
  • Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
  • Biospecimen Collection
  • +8 more
  • Scottsdale, Arizona
  • +1 more
May 16, 2023

Relapsed or Refractory Chronic Lymphocytic Leukemia, Relapsed or Refractory Small Lymphocytic Lymphoma Trial in China

Completed
Has Results
  • Relapsed or Refractory Chronic Lymphocytic Leukemia
  • Relapsed or Refractory Small Lymphocytic Lymphoma
  • Beijing, Beijing, China
  • +15 more
Sep 29, 2021

Healthy Bones, Healthy Life

Recruiting
  • Acute Lymphoblastic Leukemia, Pediatric
  • +12 more
    • Omaha, Nebraska
      University of Nebraska Medical Center
    Dec 10, 2021

    Family Study of Lymphoproliferative Disorders

    Recruiting
    • Lymphoma, Non-Hodgkin
    • +4 more
      • Rochester, Minnesota
        Mayo Clinic
      Aug 30, 2021

      Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Richter's Syndrome Trial in Italy, United Kingdom, United States

      Active, not recruiting
      Has Results
      • Chronic Lymphocytic Leukemia
      • +3 more
      • Boston, Massachusetts
      • +11 more
      Nov 23, 2022

      Orelabrutinib in the Treatment of CLL/SLL

      Not yet recruiting
      • CLL/SLL
        • (no location specified)
        Jul 26, 2023

        The Immunoscore as a Prognostic Marker for a Colorectal Cancer

        Active, not recruiting
        • Colorectal Cancer
        • Surgical Resection of the Colorectal Tumor
          • Besançon, France
          • +5 more
          Oct 11, 2021

          Leukemia, Myeloid, Acute, Leukemia, Lymphocytic, Acute Trial in United States (DS-3201b)

          Terminated
          • Leukemia, Myeloid, Acute
          • Leukemia, Lymphocytic, Acute
          • Boston, Massachusetts
          • +5 more
          Jun 11, 2021

          Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial (Nemtabrutinib, Ibrutinib, Acalabrutinib)

          Not yet recruiting
          • Chronic Lymphocytic Leukemia
          • Small Lymphocytic Lymphoma
          • (no location specified)
          Nov 22, 2023

          Relapsed or Refractory CD19+ B-cell Lymphoma, Relapsed or Refractory Chronic Lymphocytic Leukemia, Relapsed or Refractory Small

          Recruiting
          • Relapsed or Refractory CD19+ B-cell Lymphoma
          • +2 more
          • TBI-2001
          • +2 more
          • Toronto, Ontario, Canada
            Princess Margaret Cancer Centre
          Jul 26, 2023

          Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial run by the (Acalabrutinib (Arm A), Acalabrutinib (Arm B))

          Active, not recruiting
          Has Results
          • Chronic Lymphocytic Leukemia
          • Small Lymphocytic Lymphoma
          • Acalabrutinib (Arm A)
          • Acalabrutinib (Arm B)
          • Bethesda, Maryland
            Research Site
          Jan 3, 2023

          Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Trial in Worldwide (Acalabrutinib, Venetoclax, Obinutuzumab)

          Recruiting
          • Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
          • Tucson, Arizona
          • +40 more
          Dec 20, 2022

          Biomarker for Infection Risk in CLL and MM

          Not yet recruiting
          • Multiple Myeloma
          • Chronic Lymphocytic Leukemia
          • Screening
          • Boston, Massachusetts
            Massachusetts General Hospital Cancer Center
          May 3, 2023

          Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Scottsdale, Jacksonville, Rochester (drug, other, biological)

          Recruiting
          • Chronic Lymphocytic Leukemia
          • Small Lymphocytic Lymphoma
          • Scottsdale, Arizona
          • +2 more
          Jan 5, 2023

          Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Houston (Pirtobrutinib, Venetoclax)

          Recruiting
          • Chronic Lymphocytic Leukemia
          • Small Lymphocytic Lymphoma
          • Houston, Texas
            M D Anderson Cancer Center
          Nov 17, 2022

          Chronic Lymphocytic Leukemia Patients

          Not yet recruiting
          • Chronic Lymphocytic Leukemia
            • San Francisco, California
              Power Life Sciences
            Jun 2, 2023

            Calquence CLL 1L Japan PMS _ Japan Post-Marketing Surveillance

            Not yet recruiting
            • Previously Untreated Chronic Lymphocytic Leukaemia (Including Small Lymphocytic Lymphoma)
              • (no location specified)
              Dec 16, 2022

              Calquence CLL rr Japan PMS_Japan Post-Marketing Surveillance

              Active, not recruiting
              • Relapsed or Refractory Chronic Lymphocytic Leukemia (Including Small Lymphocytic Lymphoma)
                • Aichi, Japan
                • +48 more
                Dec 7, 2022

                B-cell Non Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial in Charleston (Cyclophosphamide injection, Fludarabine

                Not yet recruiting
                • B-cell Non Hodgkin Lymphoma
                • Chronic Lymphocytic Leukemia
                • Cyclophosphamide injection
                • +2 more
                • Charleston, South Carolina
                  Hollings Cancer Center at Medical University of South Carolina
                Jan 18, 2023

                Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Follicular Lymphoma Trial in United States (Zilovertamab vedotin)

                Active, not recruiting
                • Chronic Lymphocytic Leukemia
                • +11 more
                • Zilovertamab vedotin
                • Duarte, California
                • +13 more
                Jan 12, 2023

                Hematologic Malignancies Trial in Worldwide (Nemtabrutinib)

                Recruiting
                • Hematologic Malignancies
                • Torrance, California
                • +51 more
                Jan 12, 2023

                Multiple Myeloma, Chronic Lymphocytic Leukemia Trial in Durham (Myeloma Coach or CLL Coach Mobile App, Springboard Beyond Cancer

                Completed
                • Multiple Myeloma
                • Chronic Lymphocytic Leukemia
                • Myeloma Coach or CLL Coach Mobile App
                • Springboard Beyond Cancer informational website
                • Durham, North Carolina
                  Duke University
                Jun 23, 2023

                Low Bone Mineral Density, Postmenopausal Osteoporosis Trial (Placebo to Romosozumab, Alendronate, Teriparatide)

                Completed
                Has Results
                • Low Bone Mineral Density
                • Postmenopausal Osteoporosis
                • Placebo to Romosozumab
                • +6 more
                • (no location specified)
                Sep 9, 2022

                Chronic Lymphocytic Leukemia, Richter Syndrome, Small Lymphocytic Lymphoma Trial in Rochester (Acalabrutinib, Durvalumab,

                Recruiting
                • Chronic Lymphocytic Leukemia
                • +2 more
                • Rochester, Minnesota
                  Mayo Clinic in Rochester
                Jan 4, 2023

                CLL Trial (Sonrotoclax, Zanubrutinib, Venetoclax)

                Not yet recruiting
                • CLL
                • (no location specified)
                Oct 3, 2023